MSCI Inc. A Stock
MSCI Inc. A Stock
Pros and Cons of MSCI Inc. A in the next few years
Pros
Cons
Performance of MSCI Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MSCI Inc. A | 0.950% | 2.519% | -2.989% | 3.094% | -0.241% | -0.121% | -1.174% |
| Equifax Inc. | 1.070% | 0.201% | 5.053% | -28.029% | -20.794% | -19.343% | -31.955% |
| Factset Research Systems | 0.440% | 2.055% | 5.888% | -32.466% | -8.052% | -42.177% | -22.313% |
| Moodys Corp. | 0.960% | 0.000% | 0.728% | -4.223% | -5.853% | 29.283% | 30.874% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.MSCI Inc. (MSCI.US) - FY2025 Annual Report
MSCI appears to be operating from a position of robust profitability, with revenue reaching approximately $3.13 billion, representing a year-over-year increase of nearly 10%. Net income reached $1.20 billion, supported by a healthy operating margin of approximately 54.67% and a net margin of 38.36%. The company's multi-year trajectory seems stable, showcasing consistent top-line expansion and sustained high margins that underscore the recurring nature of its business model.
A closer look at the revenue streams reveals that recurring subscriptions and asset-based fees remain the primary growth engines, with the Index segment continuing to contribute the largest share of reportable segment revenues. Operating expenses grew modestly, yet the company successfully maintained its efficiency, allowing operating income to rise to over $1.71 billion. The gross margin stood at 100% based on the cost of revenues definition excluding certain items, reflecting the inherently scalable nature of MSCI's data, analytics, and index offerings.
Comments
News
Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?
Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers a significantly lower expense ratio and broader diversification than the iShares U.S. Healthcare ETF (NYSEMKT:IYH), while both hold similar
Which Consumer Staples ETF Is the Better Buy: Fidelity's FSTA or iShares' IYK?
The Fidelity MSCI Consumer Staples Index ETF (NYSEMKT:FSTA) offers a much lower expense ratio than the iShares U.S. Consumer Staples ETF (NYSEMKT:IYK), while both funds manage approximately $1.4
SPGM vs EEM: Does Global Large Cap Diversification Beat Emerging Markets Focus in 2026?
Comparison between State Street SPDR Portfolio MSCI Global Stock Market ETF (NYSEMKT:SPGM) and iShares MSCI Emerging Markets ETF (NYSEMKT:EEM) hinges on whether an investor wants targeted